(Total Views: 452)
Posted On: 12/21/2022 4:51:08 PM
Post# of 148870
Haven't even looked at lie hub in 2 years. Who is watching the DOJ website for a CYDY article to pop up and than posts it all over social media?? Shorts
I look forward to the day the hold is lifted and bashers will still be talking about NP and Amarex. We have already taken a step back when DOJ first mentioned investigations im actually really glad it also involves the crook CEO from Amarex we might have had a BLA 16 months ago if he did his job. NP selling if shares little to no impact on SP imo. You have to realize if it wasn’t this the shorts were pushing it would be something else and if they have nothing they make negative rumors up etc…
Current SP obviously frustrating but things could 180 quickly at anytime soon with a Partnership on NASH or even Cancer or maybe BIG pharma has cydy right where they want them lowest SP in years yet they now have most data positive data ever for a drug that doesn’t have an approval on any of its multiple multiple promising indications. Think about how much has been learned in past year about MOA etc.
i will be adding at every opportunity. If i was wrong about this investment i’ll go down with the ship. I believe the phase 3 hiv trial results and the patients that took Leronlimab Safely for 7 years in some cases… i believe the scientific advisors, doctors, and patient testimonials etc even if you don’t believe in what ex ceo has said.
I look forward to the day the hold is lifted and bashers will still be talking about NP and Amarex. We have already taken a step back when DOJ first mentioned investigations im actually really glad it also involves the crook CEO from Amarex we might have had a BLA 16 months ago if he did his job. NP selling if shares little to no impact on SP imo. You have to realize if it wasn’t this the shorts were pushing it would be something else and if they have nothing they make negative rumors up etc…
Current SP obviously frustrating but things could 180 quickly at anytime soon with a Partnership on NASH or even Cancer or maybe BIG pharma has cydy right where they want them lowest SP in years yet they now have most data positive data ever for a drug that doesn’t have an approval on any of its multiple multiple promising indications. Think about how much has been learned in past year about MOA etc.
i will be adding at every opportunity. If i was wrong about this investment i’ll go down with the ship. I believe the phase 3 hiv trial results and the patients that took Leronlimab Safely for 7 years in some cases… i believe the scientific advisors, doctors, and patient testimonials etc even if you don’t believe in what ex ceo has said.
(7)
(0)Scroll down for more posts ▼
